SCHEMBL5481180

SCHEMBL5481180

CC(CC(N)=O)[Si](C)(C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.42
ALOX5 P09917 4/20 0.40
RAB9A P51151 1/20 0.38
MAPT P10636 1/20 0.38
ELANE P08246 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SLC6A3 Q01959 3/20 0.35
DRD3 P35462 2/20 0.35
LMNA P02545 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
EDNRB P24530 1/20 0.35
MAPK1 P28482 1/20 0.35
MC4R P32245 1/20 0.35
MC3R P41968 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15437776 0.70 GABBR2 (0.47) CYP2C19MAPTCYP1A2CYP2D6DRD3
SCHEMBL7894538 0.70 ALOX5 (0.39) CYP2C19ALOX5MAPTCYP1A2CYP2D6
SCHEMBL353133 0.69 TAAR1 (0.54) CYP2C19ALOX5RAB9AALDH1A1CYP1A2
SCHEMBL5988113 0.69 TAAR1 (0.54) CYP2C19ALOX5RAB9AALDH1A1CYP1A2
SCHEMBL7857 0.69 TAAR1 (0.54) CYP2C19ALOX5RAB9AALDH1A1CYP1A2
SCHEMBL7773373 0.69 MAPT (0.46) CYP2C19ALOX5MAPTALDH1A1CYP1A2
SCHEMBL7899666 0.69 CPA1 (0.42) CYP2C19MAPTCYP1A2
Hydrochloric Acid SCHEMBL27791133 0.68 TAAR1 (0.52) CYP2C19ALOX5RAB9AALDH1A1CYP1A2
SCHEMBL2012876 0.68 SLC6A2 (0.39) ALDH1A1CYP2D6SLC6A3LMNA
SCHEMBL5068915 0.68 NR1H2 (0.52) CYP2C19ALDH1A1CYP2D6PKMSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737471-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF LIPOPHILIC, SILICON-SUBSTITUTED, CYCLOOXYGENASE-2 SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND DERIVATIVES RND Pharmaceuticals (US) 2007-01-03 EP claimed
WO-2005102358-A2 SILICONE-SUBSTITUTED COX-2 SELECTIVE INHIBITORS RND PHARMACEUTICALS (US) 2005-11-03 WO claimed